The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary safety and activity of nivolumab and its combination with ipilimumab in recurrent glioblastoma (GBM): CHECKMATE-143.
 
John H. Sampson
No Relationships to Disclose
 
Gordana Vlahovic
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Solmaz Sahebjam
Research Funding - Cortice Biosciences (Inst)
 
Antonio Marcilio Padula Omuro
Consulting or Advisory Role - Novartis; Novocure; Roche Pharma AG; Stemline Therapeutics
 
Joachim M. Baehring
Consulting or Advisory Role - Bristol-Myers Squibb
 
David A Hafler
Employment - Sanofi
Honoraria - Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Genzyme; Novartis
Research Funding - Bristol-Myers Squibb
 
Alfredo Daniel Voloschin
No Relationships to Disclose
 
Prashni Paliwal
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Joseph Grosso
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Vlad Coric
Employment - Bristol-Myers Squibb
 
Timothy F. Cloughesy
Consulting or Advisory Role - Celgene; Genentech; Lpath; NewGen Therapeutics; Proximagen; Roche Pharma AG; Tocagen; VBL Therapeutics
Expert Testimony - Roche Pharma AG
 
Michael Lim
Honoraria - Accuray; Stryker
Consulting or Advisory Role - Stryker
Research Funding - Agenus; Arbor Pharmaceuticals; Bristol-Myers Squibb; Celldex; ImmunoCellular Therapeutics; Stryker
Patents, Royalties, Other Intellectual Property - Johns Hopkins University
 
David A. Reardon
No Relationships to Disclose